Birka\u00e7 bin hastadan olu\u015fan \u00f6nerilen s\u0131n\u0131f, Cigna ve onun faturaland\u0131rma s\u00f6zle\u015fmesi MultiPlan'\u0131n, madde kullan\u0131m bozuklu\u011fu tedavileri i\u00e7in a\u011f d\u0131\u015f\u0131 iddialar\u0131 eksik \u00f6demek i\u00e7in gizli anla\u015fmalar yaparak ERISA'y\u0131 ihlal etti\u011fini iddia ediyor. <\/p>\n\n\n\n
Law360'\u0131n bildirdi\u011fi gibi: <\/p>\n\n\n\n
The proposed class said that for all claims at issue, Cigna verified to patients’ providers on the phone that claims for mental health and substance use disorder treatments would be reimbursed at what’s known as the “usual, customary and reasonable,” or UCR, rate. The UCR rate is a composite rate based on similar providers in the same geographic area. But when claims were later priced using a methodology of MultiPlan subsidiary Viant, reimbursements were calculated using much lower rates, the proposed class said, in a scheme that they allege violated the Racketeer Influenced and Corrupt Organizations Act.<\/p>\n\n\n\n
Napoli Shkolnik K\u0131demli Yard\u0131mc\u0131s\u0131 Wendy A. Mitchel<\/a>l, di\u011fer hukuk firmalar\u0131yla birlikte \u00f6nerilen s\u0131n\u0131f\u0131 temsil eder. <\/p>\n\n\n\n